Biogen Idec (BIIB) has been running higher over the past 30 minutes and is up $1.84 to $51.47 on takeover chatter. It’s unsubstantiated, but heavy trading in April 55, April 60, and May 60 calls is accompanying the move higher in BIIB shares.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.